In pancreatic cancer patients receiving FOLFIRINOX, tumor size reduction significantly increased resectability and pathologic response. Normalization of carbohydrate antigen 19-9 levels predicted resectability, lower recurrence risk, and improved survival. Postoperative antigen 19-9 rise, following prior normalization after neoadjuvant therapy, signaled heightened recurrence risk and poorer survival. Tailoring treatment response assessments can guide personalized strategies for […]
Category: HPB & Spleen
Sarcopenia Signals Poor Outcomes in Recurrent Hepatocellular Carcinoma
Patients with early-stage recurrent hepatocellular carcinoma and sarcopenia face significantly lower overall and recurrence-free survival rates, regardless of treatment type. Sarcopenia emerges as an independent prognostic factor, suggesting a crucial role in long-term outcomes. Notably, impaired host immunity, evidenced by low levels of tumor-infiltrating lymphocytes, may contribute to the unfavorable prognosis. This study underscores the […]
Optimizing Laparoscopic Pancreaticoduodenectomy: ‘1+2’ Stitch Shows Superiority in Pancreaticojejunostomy
In a game-changing move, researchers explored the “1+2” technique for pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. Among 184 cases, this approach exhibited success in all 95 “1+2” cases, showcasing advantages over the traditional method. The new technique boasted shorter operation and pancreaticojejunostomy times, reduced complications, lower infection rates, and briefer hospital stays. Results suggest that this innovative […]
Laparoscopic Limited Anatomic Liver Resections: Precise Technique Yields Promising Oncologic Outcomes
Exploring laparoscopic liver surgeries, researchers scrutinized 112 patients undergoing laparoscopically limited anatomic resections (LARs) for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). Impressively, lap-LAR demonstrated precise technique, yielding promising oncologic outcomes with low complications. Five-year recurrence-free survival rates for HCC and CRLM stood at 45.1% and 36.8%, showcasing lap-LAR’s potential as an effective therapeutic […]
Surviving Biliary Sepsis: Unveiling 90-Day Mortality and Risks
Surviving biliary sepsis: A retrospective study in a cancer center unveils a 30.3% 90-day mortality rate, with factors like metastatic stage, biliary tract tumor compression, and multi-drug resistant bacteria influencing outcomes. Antibiotic de-escalation emerges as a safe strategy, linked with better survival. Beyond organ dysfunctions, the study emphasizes the impact of cancer stage, bacteria colonization, […]
Unveiling Hepatitis D: High Impact on Liver Health and a New Player in the Treatment Game
Hepatitis D Virus (HDV) hitchhikes on Hepatitis B Virus (HBV), impacting 12 to 72 million globally with accelerated liver disease progression. Chronic HDV-HBV infection, deadlier than HBV alone, leads to cirrhosis and hepatocellular carcinoma. Limited awareness hampers diagnosis, but the HBV vaccine offers prevention. Interferon alfa shows efficacy, while bulevirtide and lonafarnib present promising therapies. […]
Unlocking Hope for Neuroendocrine Carcinomas: Spheroid Screening Points to DNA Repair Inhibitors
In the quest for effective gastroenteropancreatic neuroendocrine carcinoma treatments, researchers unleashed patient-derived tumor spheroids. A dazzling 16 compounds, notably tyrosyl-DNA phosphodiesterase 1 inhibitors, emerged as fierce warriors against over 75% of these rare tumors. Cytarabine, a standout from the bunch, synergized with standard drugs, intensifying the battle against cancer cells. These findings spotlight a promising […]
Endoscopic Management Prevails Over Surgery in Infected Necrotizing Pancreatitis: Meta-Analysis Findings
For severe infected necrotizing pancreatitis, researchers compared endoscopic and minimally invasive surgical (MIS) treatments in a meta-analysis. Analyzing five randomized controlled trials with 284 patients, endoscopic procedures (145 patients) outperformed MIS (139 patients), demonstrating significantly lower complication rates and better patient quality of life. Journal Article by Tang P, Ali K (…) Zhang W et […]
Racial Disparities and Socioeconomic Factors Shape Pancreaticoduodenectomy Hospital Choices in the U.S.
In the U.S., racial disparities exist in the choice of high- or low-volume hospitals for pancreaticoduodenectomy (PD) surgeries, impacting outcomes. A review of 30 studies reveals that more racial minorities undergo PD in low-volume hospitals. Additionally, disparities in travel distance, education levels, and median income between high- and low-volume hospitals were noted. This study underscores […]
Arterial Resection in Pancreatic Cancer: Weighing Feasibility, Morbidity, and Necessity in High-Volume Centers
In the quest for curative pancreatectomy for pancreatic cancer, researchers delve into arterial resection’s (AR) feasibility and outcomes. Analyzing 259 patients, they find AR, despite longer operation times, rivals venous resection in morbidity. Surprisingly, arterial infiltration’s likelihood is questioned, suggesting AR might be replaceable by less invasive techniques. This study at a high-volume pancreatic surgery […]